| Document Date: 2011-02-04 14:55:20
Open Document File Size: 130,55 KBShare Result on Facebook
City Sustained / Reference / / Company Anesthesia / VF / / Event Product Recall / Product Issues / FDA Phase / / Facility Blood Institute / / MedicalCondition anaphylactic reaction / allergic reaction / ventricular tachycardia / Thyrotoxicosis Beta-blockade / thyrotoxicosis / left ventricular dysfunction / sinus node dysfunction / ischemic heart disease / cardiomegaly / hyperthyroidism / syncope / Torsade de Pointes / Pulmonary / angina pectoris / marked bradycardia / asystole / disorder / bradycardia / tachycardia / angina / hypersensitivity / sustained ventricular tachycardia / Sinus bradycardia / hypoglycemia / Abrupt Withdrawal Hypersensitivity / chronic bronchitis / atrial flutter / hypotension / arrhythmia / induced arrhythmia / congestive heart failure / bronchial asthma / Protracted severe hypotension / oral antidiabetics Hyperglycemia / acute hypoglycemia / emphysema / spontaneous hypoglycemia / Carcinogenesis / cardiac arrhythmias / chronic / prolonged diarrhea / stroke / diabetes / AV block / sick sinus syndrome / myocardial infarction / heart failure / pheochromocytoma / thyroid storm / cardiogenic shock / coronary artery disease / ventricular fibrillation / rebound hypertension / atrial fibrillation / Non-Allergic Bronchospasm / tachyarrhythmias / hypokalemia / worsened heart failure / especially labile diabetes / / MedicalTreatment antibiotics / concomitant therapy / major surgery / resuscitation / cardioversion / / Organization National Institute of Health / Antacids Administration of Betapace / DOSAGE AND ADMINISTRATION / / / Position physician / / Product reserpine / BETAPACE / Hypersensitivity / sotalol hydrochloride / Betapace AF / Digoxin / epinephrine / Beta-2 / hydrochlorothiazide / renal function / / ProvinceOrState Vermont / / Technology AV / Pharmacokinetics / pharmacodynamics / /
SocialTag |
BETAPACE (sotalol HCl) To minimize the risk of induced arrhythmia, patients initiated or reinitiated on Betapace should be placed for a minimum of three days (on their maintenance dose) in a facility that can provide car